| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |